COVID & Psychedelics: 3 Biotech Penny Stocks To Watch In August
“With coronavirus cases climbing in the U.S., this is likely going to be a clear focus for quite some time,” declares the author of today’s…
Biotech Stocks
“The Era Of Biotechs”
“The paralyzing viral outbreak that has swept the planet, costing trillions in output and gumming up the wheels of the global economy has also created…
U.S. Traders May Be Accidentally Buying This Biotech Stock – But It May Be Worth Owning Anyways!
Shares of the biotech highlighted in today’s article have soared this year, but is this performance due to factors such as the COVID-19 drug the…
What To Know About These Top Biotech Stocks To Watch
“July is a critical month for several leading biotech companies, and there’s a lot that investors need to know if they want to make a…
Follow The Analysts To Massive Upside Potential From These 3 Micro-Cap Stocks
“If you are looking to hit a home run in the stock market, the NASDAQ Composite is a good place to start,” advises the author…
Biotech Boomers To Buy
When it comes to biotech stocks, the author of today’s article advises that “While you can get access to many of these firms via exchange-traded…
Why These 2 Under-The-Radar Biotech Stocks Are Poised To Dominate This Year And Beyond
The two small-cap biotech stocks highlighted in today’s article appear poised to dominate this year and beyond. Why? As the author explains, “Both companies are…
“Focus On The Fundamentals”: 2 Biotech Stocks With Upcoming Catalysts Unrelated To COVID-19
“This pandemic-driven frenzy for drugmaker stocks has made it awfully hard for investors who like to focus on the fundamentals,” notes the author of today’s…
Why A COVID-19 Vaccine Could Be Approved Before The November Election – And Who The Real Winners Would Be
Could a COVID-19 vaccine – or vaccines – be approved before the November election? That’s the bold prediction being made by Jefferies – and if…
Large And Small, These Biotech Stocks Could Be Big Winners
One large-cap biotech and two small-cap biotechs – one which “has been content with staying out of the limelight” and a second, higher-risk play –…